Get the newest information from the Immunization Program right in your inbox!
Sign up
Trouble logging in? Forgot password? We can help!
215-685-6784
215-238-6944
Complete the online reporting agreement form
Or fill out the
then email it to
vaxreporting@phila.gov
or fax to the contact above.
Complete in addition to the reporting agreement form to onboard more than 2 clinics.
Need help? Review the FAQ
National Infant Immunization Week highlights the importance of protecting children two years and younger from vaccine-preventable diseases. Research consistently shows that healthcare professionals are the most trusted source of vaccine information for parents. We encourage you to use this opportunity to emphasize the importance of timely...
Based on decreased RSV test positivity and pediatric hospitalizations, the Philadelphia Department of Public Health recommends stopping RSV monoclonal antibody immunization (i.e., nirsevimab and clesrovimab) to all eligible patients on April 15, 2026. Administration may continue until April 30, 2026, based on clinical judgment. Due to...
Join us for a training on pediatric immunization techniques on Friday, May 8, 2026! The Immunization Program is hosting a free training on pediatric immunization techniques for practitioners who administer or will administer Vaccines for Children (VFC) immunizations to pediatric patients. We encourage attendance by RNs,...
Adolescent Immunization Action Week (AIAW) reminds us to keep adolescents up-to-date on immunizations that protect against potentially life-threatening diseases like meningitis, tetanus, diphtheria, pertussis, HPV-related cancers, COVID-19, and influenza. Unity® Consortium offers digital and print resources that you can access online, share, or print. See below: Webinar:...
We recently migrated our SFTP services to a new server. Because of this move, the Server Host Key has changed. If the service account or automated script is failing to connect, it is likely because your system still has the old server identity saved in its...
Re-Enrollment Opens May 1, 2026 The Philadelphia Vaccines for Children (VFC) and the Vaccines for Adults at Risk (VFAAR) annual re-enrollment period will take place May 1 - 31, 2026 using PhilaVax. Complete the steps below to prepare for re-enrollment. Prepare for Re-Enrollment Make sure all required staff have...
The current SFTP will be unavailable beginning on Friday, March 20, 2026 at 4 p.m. through Monday, March 23, 2026 at 10 a.m. The secure file transport portal (SFTP), is a secure web-based application that acts as a conduit for secure communications and exchange of data...
PhilaVax will be temporarily closed to new orders from Monday, March 30, 2026 through Wednesday, April 1, 2026 while immunization prices are updated for 2026. Any orders entered into PhilaVax IIS during this time will be deleted from the system and not processed. If you need to...
Increased disease activity indicates season extension The Philadelphia Department of Public Health recommends offering RSV monoclonal antibody immunization (i.e., nirsevimab and clesrovimab) to all eligible patients until April 15, 2026 due to continued RSV hospitalizations. Federally purchased RSV immunization will no longer be available to order after...
Set Up Multi-Factor Authentication The secure file transport portal (SFTP), is a secure web-based application that acts as a conduit for secure communications and exchange of data between providers and the Philadelphia Department of Public Health (PDPH).We are writing to inform you of an upcoming security...
Nationally, COVID-19 activity is increasing from low levels. Continuing to vaccinate is important in protecting vulnerable individuals, such as infants, against the disease. Infants and children between 6 months and 23 months of age are at high risk of severe COVID-19. Children with certain medical conditions, such as asthma and congenital...
There are no changes in vaccine recommendations and availability in Philadelphia. On Monday, January 5, 2026, the Centers for Disease Control and Prevention (CDC) updated the pediatric immunization schedule, changing several routine childhood vaccines from a routine recommended category to a shared-decision-making and/or high-risk category. Despite these...
RSV activity is elevated in many areas of the country, including Pennsylvania and Philadelphia. RSV (respiratory syncytial virus) immunization remains the most effective protection against RSV illness. A recent study showed that nirsevimab was 81% effective against RSV-associated hospitalization among infants younger than 6 months. Refer to these previous messages regarding availability and...
Prepare for Winter: Protect Your Patients and Your Vaccine Supply Take steps now to keep your vaccine supply safe and your clinic running smoothly through the winter months. Power Outages Review and update your Vaccine Management Plan to ensure all staff know what to do if there’s a power outage...
There is increasing influenza disease activity in parts of the U.S. The most recent weekly CDC influenza surveillance report shows one influenza-associated pediatric death, bringing the 2025-2026 season total to nine reported influenza-related pediatric deaths. CDC estimates that there have been at least 11,000,000 illnesses,...
Dear PhilaVax Users,The Philadelphia Department of Public Health (PDPH) Immunization Program is currently undergoing its annual PhilaVax user account renewal.All users must complete the user agreement for the 2026 calendar year for continued access to PhilaVax. All agreements must be completed by February 9th, 2026. Users without...
The hepatitis B vaccine has saved millions of lives. Since its implementation in 1991, hepatitis B vaccination at birth has reduced pediatric hepatitis B infections by 99%.When discussing hepatitis B vaccination with patients, especially the hepatitis B birth dose, frame the choice clearly: the hepatitis B vaccine...
Addressing aluminum, shared decision-making, combination vaccines, & more Patients have questions about vaccines, and we’re here to support you in these discussions so you can remain a trusted source. Our Guide to Talking Vaccines with Adults, vaccine facts webpage, and Vaccine Hesitancy and Refusal Guide are good starting points for...